m 8218 has been researched along with scopolamine hydrobromide in 1 studies
| Studies (m 8218) | Trials (m 8218) | Recent Studies (post-2010) (m 8218) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 118 | 24 | 80 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | m 8218 (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, SL; Hu, B; Ma, TF; Ma, X; Qin, SJ; Wang, Y; Yan, JZ; Zhang, Y; Zhou, CH; Zhou, L | 1 |
1 other study(ies) available for m 8218 and scopolamine hydrobromide
| Article | Year |
|---|---|
A selective M1 and M3 receptor antagonist, penehyclidine hydrochloride, prevents postischemic LTP: involvement of NMDA receptors.
Topics: Animals; Brain Ischemia; Hippocampus; Long-Term Potentiation; Male; Neuroprotective Agents; Potassium Channel Blockers; Protein Kinase C; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Receptors, N-Methyl-D-Aspartate; Scopolamine; Small-Conductance Calcium-Activated Potassium Channels | 2013 |